Literature DB >> 15884136

Analyses of prognostic indices of chronic liver failure caused by hepatitis virus.

Xiao-Mao Li1, Lin Ma, Yue-Bo Yang, Zhong-Jie Shi, Shui-Sheng Zhou.   

Abstract

AIM: To analyze the related indices about the prognoses of chronic liver failure caused by hepatitis virus.
METHODS: Retrospectively reviewed 320 cases of chronic liver failure caused by hepatitis viruses. An improved group and an ineffective group (IG) were made to compare and analyze their clinical manifestations, laboratory examination indices and complications. Logistic regression was also carried out.
RESULTS: There were significant differences (P<0.05) between the improved group and the IG upon such indices as age, bilirubin, prothrombin time, albumin, alpha fetoprotein, the size of liver and complications (P<0.05). The regression formula was as follows: P = 1/(1+e(-y)) (y = 1.7262-0.0948X(1)+2.9846X(2)+0.6992X(3)+1.6019X(4)+ 2.0398X(5)). (Note: X(1)-Prothrombin activity; X(2)-digestive tract hemorrhage; X(3)-hepatic encephalopathy; X(4)-hepatorenal syndrome; X(5)-pulmonary infection.).
CONCLUSION: Laboratory examination such as bilirubin, prothrombin time and alpha fetoprotein can be regarded as indices of the prognoses of chronic liver failure caused by hepatitis. Moreover, the regression equation can evaluate prognoses more comprehensively and direct our treatments.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15884136      PMCID: PMC4305930          DOI: 10.3748/wjg.v11.i18.2841

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  15 in total

1.  Survival after liver transplantation in the United States: a disease-specific analysis of the UNOS database.

Authors:  Mark S Roberts; Derek C Angus; Cindy L Bryce; Zdenek Valenta; Lisa Weissfeld
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

2.  Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.

Authors:  Douglas M Heuman; Souheil G Abou-Assi; Adil Habib; Leslie M Williams; R Todd Stravitz; Arun J Sanyal; Robert A Fisher; Anastasios A Mihas
Journal:  Hepatology       Date:  2004-10       Impact factor: 17.425

Review 3.  A model to predict survival in patients with end-stage liver disease.

Authors:  P S Kamath; R H Wiesner; M Malinchoc; W Kremers; T M Therneau; C L Kosberg; G D'Amico; E R Dickson; W R Kim
Journal:  Hepatology       Date:  2001-02       Impact factor: 17.425

4.  Lethal effect of the anti-Fas antibody in mice.

Authors:  J Ogasawara; R Watanabe-Fukunaga; M Adachi; A Matsuzawa; T Kasugai; Y Kitamura; N Itoh; T Suda; S Nagata
Journal:  Nature       Date:  1993-08-26       Impact factor: 49.962

5.  Summary report of a national conference: Evolving concepts in liver allocation in the MELD and PELD era. December 8, 2003, Washington, DC, USA.

Authors:  Kim M Olthoff; Robert S Brown; Francis L Delmonico; Richard B Freeman; Sue V McDiarmid; Robert M Merion; J Michael Millis; John P Roberts; Abraham Shaked; Russell H Wiesner; Michael R Lucey
Journal:  Liver Transpl       Date:  2004-10       Impact factor: 5.799

6.  Potential predictive value of the MELD score for short-term mortality after liver transplantation.

Authors:  G Santori; E Andorno; A Antonucci; N Morelli; G Bottino; R Mondello; R Valente; F Panaro; F Ravazzoni; S Di Domenico; A Savelli; U Valente
Journal:  Transplant Proc       Date:  2004-04       Impact factor: 1.066

7.  Utility of MELD and Child-Turcotte-Pugh scores and the Canadian waitlisting algorithm in predicting short-term survival after liver transplant.

Authors:  Salem M Bazarah; Kevork M Peltekian; Vivian C McAlister; Heinrich Bitter-Suermann; Alan S MacDonald
Journal:  Clin Invest Med       Date:  2004-08       Impact factor: 0.825

8.  Pretransplant MELD score and post liver transplantation survival in the UK and Ireland.

Authors:  Mathew Jacob; Lynn P Copley; James D Lewsey; Alex Gimson; Giles J Toogood; Mohamed Rela; Jan H P van der Meulen
Journal:  Liver Transpl       Date:  2004-07       Impact factor: 5.799

9.  Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models.

Authors:  M Leist; F Gantner; I Bohlinger; G Tiegs; P G Germann; A Wendel
Journal:  Am J Pathol       Date:  1995-05       Impact factor: 4.307

10.  Lessons learned from one hundred right lobe living donor liver transplants.

Authors:  Chung-Mau Lo; Sheung Tat Fan; Chi Leung Liu; Boon Hun Yong; Yik Wong; George K Lau; Ching Lung Lai; Irene O Ng; John Wong
Journal:  Ann Surg       Date:  2004-07       Impact factor: 12.969

View more
  8 in total

1.  Noninvasive predictive models of liver fibrosis in patients with chronic hepatitis B.

Authors:  Ruijie Wan; Huimin Liu; Xianbo Wang; Gang Wan; Xiaojing Wang; Guiqin Zhou; Yuyong Jiang; Fengxia Sun; Zhiyun Yang
Journal:  Int J Clin Exp Med       Date:  2015-01-15

2.  Survival and prognostic factors in hepatitis B virus-related acute-on-chronic liver failure.

Authors:  Kun Huang; Jin-Hua Hu; Hui-Fen Wang; Wei-Ping He; Jing Chen; Xue-Zhang Duan; Ai-Min Zhang; Xiao-Yan Liu
Journal:  World J Gastroenterol       Date:  2011-08-07       Impact factor: 5.742

3.  Portalsystemic hemodynamic changes in chronic severe hepatitis B: An ultrasonographic study.

Authors:  Zhong-Zhen Su; Hong Shan; Wei-Min Ke; Bing-Jun He; Rong-Qin Zheng
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

Review 4.  Management of chronic hepatitis B in pregnancy.

Authors:  Guo-Rong Han; Chuan-Lu Xu; Wei Zhao; Yong-Feng Yang
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

5.  Long Noncoding RNA AC007639.1 Promotes the Pathogenesis and Progression of Hepatocellular Carcinoma Through Inhibiting Apoptosis and Stimulating Chemotherapeutic Resistance.

Authors:  Yun Bai; Meijuan Ding; Dan Lu; Yiwen Li; Shuai Yao; Lei Wang; Hui Li; Guanghua Cui; Xue Li; Xiaoke Sun; Yu Yang
Journal:  Front Oncol       Date:  2021-09-02       Impact factor: 6.244

6.  Clinical Non-invasive Model to Predict Liver Inflammation in Chronic Hepatitis B With Alanine Aminotransferase ≤ 2 Upper Limit of Normal.

Authors:  Shanshan Chen; Haijun Huang
Journal:  Front Med (Lausanne)       Date:  2021-06-02

7.  Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure.

Authors:  Zhao-Ni Lin; Yong-Qing Zuo; Peng Hu
Journal:  Hepat Mon       Date:  2014-04-07       Impact factor: 0.660

8.  Prediction of survival after liver transplantation for chronic severe hepatitis B based on preoperative prognostic scores: a single center's experience in China.

Authors:  Liang Xiao; Zhi-Ren Fu; Guo-Shan Ding; Hong Fu; Zhi-Jia Ni; Zheng-Xin Wang; Xiao-Min Shi; Wen-Yuan Guo; Jun Ma
Journal:  World J Surg       Date:  2009-11       Impact factor: 3.352

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.